From February 7, 2024 to March 31, 2024, the company has repurchased 2,718,010 shares, representing 3.04% for CNY 87.02 million. With this, the company has completed the repurchase of 2,718,010 shares, representing 3.04% for CNY 87.02 million under the buyback announced on February 8, 2024.
Beijing Hotgen Biotech Co., Ltd.
Equities
688068
CNE100003P82
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.56 CNY | +0.24% | +0.99% | -37.73% |
1st Jan change | Capi. | |
---|---|---|
-37.73% | 305M | |
-4.42% | 179B | |
-2.01% | 100B | |
-6.73% | 46.16B | |
+18.16% | 44.81B | |
+9.73% | 44.38B | |
+13.99% | 29.53B | |
+22.31% | 25.83B | |
-7.08% | 23.97B | |
+3.64% | 22.5B |
- Stock Market
- Equities
- 688068 Stock
- News Beijing Hotgen Biotech Co., Ltd.
- Tranche Update on Beijing Hotgen Biotech Co., Ltd.'s Equity Buyback Plan announced on February 8, 2024.